CR9346A - Celulas estromaticas de adulto derivadas de tejido adiposo que exhiben caracteristicas de celulas endoteliales - Google Patents

Celulas estromaticas de adulto derivadas de tejido adiposo que exhiben caracteristicas de celulas endoteliales

Info

Publication number
CR9346A
CR9346A CR9346A CR9346A CR9346A CR 9346 A CR9346 A CR 9346A CR 9346 A CR9346 A CR 9346A CR 9346 A CR9346 A CR 9346A CR 9346 A CR9346 A CR 9346A
Authority
CR
Costa Rica
Prior art keywords
adipose tissue
stromatic
cells
display characteristics
endotelial
Prior art date
Application number
CR9346A
Other languages
English (en)
Inventor
K Hendricks James
B Ii Mitchell James
Original Assignee
Cognate Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognate Therapeutics Inc filed Critical Cognate Therapeutics Inc
Publication of CR9346A publication Critical patent/CR9346A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/069—Vascular Endothelial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
    • C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
    • C12N2506/1384—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from adipose-derived stem cells [ADSC], from adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invencion abarca una celula estromatica de adulto derivada de tejido adiposo (ADAS), que exhibe por lo menos una caracteristica de una celula prendotelial y/o una celula endotelial, la presente invencion abarca tambien composiciones y metodos para generar una celula estromatica de adullto derivada de tejido adiposo que exhibe por lo menos una caracteristica de una celula preendotelial y /o una celula endotelial.
CR9346A 2005-01-31 2007-08-28 Celulas estromaticas de adulto derivadas de tejido adiposo que exhiben caracteristicas de celulas endoteliales CR9346A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64863005P 2005-01-31 2005-01-31

Publications (1)

Publication Number Publication Date
CR9346A true CR9346A (es) 2008-02-12

Family

ID=36778041

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9346A CR9346A (es) 2005-01-31 2007-08-28 Celulas estromaticas de adulto derivadas de tejido adiposo que exhiben caracteristicas de celulas endoteliales

Country Status (14)

Country Link
US (1) US20060171932A1 (es)
EP (1) EP1859025A4 (es)
JP (1) JP2008528041A (es)
KR (1) KR20070100908A (es)
CN (1) CN101155912A (es)
AU (1) AU2006210425A1 (es)
BR (1) BRPI0607045A2 (es)
CA (1) CA2596281A1 (es)
CR (1) CR9346A (es)
IL (1) IL184890A0 (es)
MX (1) MX2007009173A (es)
RU (1) RU2007132733A (es)
TW (1) TW200637911A (es)
WO (1) WO2006084284A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142094A0 (en) 1998-09-29 2002-03-10 Gamida Cell Ltd Methods of controlling proliferation and differentiation of stem and progenitor cells
IL152904A0 (en) * 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (en) 2002-01-25 2006-06-07 Gamida Cell Ltd PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED
JP2005520511A (ja) * 2002-03-18 2005-07-14 ガミダ セル リミテッド エクスビボ拡大培養された幹細胞における分化を誘導する方法
US20050054097A1 (en) * 2002-11-17 2005-03-10 Tony Peled EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
WO2006030442A2 (en) 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
WO2008056368A2 (en) * 2006-11-09 2008-05-15 Gamida-Cell Ltd. Use of ex-vivo cultured hematopoietic cells for treatment of peripheral vascular diseases
US20080299077A1 (en) * 2007-06-01 2008-12-04 Nevada Cancer Institute Isolation and growth of stem cells from hemangiomas
WO2008151021A1 (en) * 2007-06-01 2008-12-11 Nevada Cancer Institute Isolation and growth of stem cells from hemangiomas
US9096827B2 (en) * 2008-09-02 2015-08-04 Pluristem Ltd. Adherent cells from placenta tissue and use thereof in therapy
WO2010045645A1 (en) * 2008-10-17 2010-04-22 Baxter International Inc. Methods of obtaining cell populations from adipose tissue
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
WO2012135237A2 (en) * 2011-03-28 2012-10-04 Arnone John S Business methods, processes and systems for collection, cryogenic storage and distribution of cosmetic formulations from an obtained stem cell based biological material
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
WO2013121426A1 (en) 2012-02-13 2013-08-22 Gamida-Cell Ltd. Culturing of mesenchymal stem cells
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
WO2015017500A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
KR101719743B1 (ko) 2015-04-06 2017-03-24 박준한 지방 조직으로부터 지방줄기세포를 수득하는 방법
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
CN106520691A (zh) * 2016-12-30 2017-03-22 潍坊医学院 一种皮肤间充质干细胞的分离及培养方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
US4678470A (en) * 1985-05-29 1987-07-07 American Hospital Supply Corporation Bone-grafting material
US5283187A (en) * 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
DE3829766A1 (de) * 1988-09-01 1990-03-22 Akzo Gmbh Verfahren zur herstellung von membranen
US4968859A (en) * 1988-10-21 1990-11-06 Westinghouse Electric Corp. Circuit breaker with low voltage contact structure
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5084350A (en) * 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
US5618531A (en) * 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
US5571083A (en) * 1994-02-18 1996-11-05 Lemelson; Jerome H. Method and system for cell transplantation
US6342479B1 (en) * 1997-04-08 2002-01-29 Societe De Counseils De Recherches Et D'applications Scientifiques, Sas Prolonging survival of transplanted pancreatic cells
US5968829A (en) * 1997-09-05 1999-10-19 Cytotherapeutics, Inc. Human CNS neural stem cells
US6153432A (en) * 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
EP1261694B1 (en) * 2000-02-26 2008-01-16 Artecel, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
CN1596303A (zh) * 2001-11-09 2005-03-16 阿特塞尔科学公司 利用基质细胞支持胚胎干细胞和成体干细胞的方法和组合物
WO2003060077A2 (en) * 2001-12-21 2003-07-24 Immunex Corporation Endothelial stem cells, populations, methods of isolation and use thereof
AU2003220424A1 (en) * 2002-03-19 2003-10-08 Advanced Research And Technology Transfer Adipose stromal stem cells for tissue and vascular modification

Also Published As

Publication number Publication date
TW200637911A (en) 2006-11-01
EP1859025A2 (en) 2007-11-28
CA2596281A1 (en) 2006-08-10
US20060171932A1 (en) 2006-08-03
CN101155912A (zh) 2008-04-02
RU2007132733A (ru) 2009-03-10
IL184890A0 (en) 2007-12-03
EP1859025A4 (en) 2009-07-22
JP2008528041A (ja) 2008-07-31
BRPI0607045A2 (pt) 2009-08-04
KR20070100908A (ko) 2007-10-12
WO2006084284A3 (en) 2006-09-28
WO2006084284A2 (en) 2006-08-10
MX2007009173A (es) 2008-03-10
AU2006210425A1 (en) 2006-08-10

Similar Documents

Publication Publication Date Title
SV2009003392A (es) Aril pirrolidinas insecticidas
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
EA200901109A1 (ru) Применение n-фениламидинов в качестве гербицидов
CU23978B1 (es) Composiciones para anticuerpos que se dirigen a la proteína de complemento c5
MX336875B (es) Sal de besilato de un inhibidor de tirosina cinasa de bruton (btk).
MX383346B (es) Composiciones y metodos que comprenden variantes de serina proteasa.
ECSP12011939A (es) Compuestos Lipopéptidos y métodos relacionados
MX2010002028A (es) Metodos y composiciones para modular celulas t.
ES2571041T3 (es) Composiciones antimicrobianas
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
ATE473744T1 (de) Modifizierte pyrimidin-glucocorticoid-rezeptor- modulatoren
HN2009000566A (es) Nuevos derivados de diosmetina, su procedimiento de prearacion y las composiciones farmaceuticas que lo contienen.
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
CR20200342A (es) Composiciones de edb que se dirigen a il-12
AR074270A1 (es) Composicion de champu concentrada
BRPI0607045A2 (pt) células estromais adultas derivadas de adiposas exibindo caracterìsticas de células endoteliais
MX2007008723A (es) Polipeptidos de yersinia spp y metodos de uso.
UY31012A1 (es) Formas solidas de la oxima de la (e)-1-(4-((1r, 2s, 3r)-1,2,3,4-tetrahidroixibutil)-1h-imidazol-2-il)etanona
PA8667201A1 (es) Nuevos compuestos farmaceuticos
MX2019014503A (es) Metodos y materiales para cultivar, proliferar, y diferenciar celulas madre.
GT200600414A (es) Sal de glucuranato de compuesto de piperazine
EP2446023A4 (en) ADULT ANIMALS CREATED FROM INDUCED PLURIPOTENTIAL CELLS
GT200600173A (es) Forma purificada de tranaproget
CY1114113T1 (el) Συνδυασμος ενος αναστολεα του κολπικου ρευματος if και ενος βητα-αναστολεα

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)